Work

PcrV in an intranasal adjuvanted tobacco mosaic virus conjugate vaccine mediates protection from Pseudomonas aeruginosa via an early Th1/Th17 skewed localized and systemic immune response.

Year: 2025

Type: article

Source: Vaccine

DOI: 10.1016/j.vaccine.2025.127306

Authors: Adiya S. Katseff, Christina Toumanios, Eman Barahim, Alison A. McCormick, Paul M. Arnaboldi

Institutions: New York Medical College, University of Jeddah, University of California, Davis

Language: English

Topic: Bacterial Infections and Vaccines

Subfield: Microbiology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: Touro University California, New York Medical College, National Institutes of Health, Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases

Awards: G6315151857, G9000189167

OpenAlex ID: W4410733161

FWCI: 0.461

Cites: 64

Cited by: 1

Related to: 10